Variant report
Variant | nsv822029 |
---|---|
Chromosome Location | chr3:21490121-21490623 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183078626 | chr3:21490134-21490135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs424695 | chr3:21490145-21490146 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs116177752 | chr3:21490154-21490155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577032946 | chr3:21490155-21490156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115134405 | chr3:21490197-21490198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7647569 | chr3:21490234-21490235 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs390039 | chr3:21490246-21490247 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs111431934 | chr3:21490247-21490248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs446720 | chr3:21490248-21490249 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs563022993 | chr3:21490251-21490252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530555298 | chr3:21490287-21490288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139183397 | chr3:21490296-21490297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533789681 | chr3:21490311-21490312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201169245 | chr3:21490355-21490356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs63456861 | chr3:21490356-21490357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189043723 | chr3:21490407-21490408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs453990 | chr3:21490422-21490423 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs447169 | chr3:21490448-21490449 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547329351 | chr3:21490457-21490458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568813328 | chr3:21490466-21490467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4597731 | chr3:21490473-21490474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529505685 | chr3:21490521-21490522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551222236 | chr3:21490525-21490526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201030224 | chr3:21490563-21490564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201225051 | chr3:21490564-21490565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201448277 | chr3:21490567-21490568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs199785357 | chr3:21490568-21490569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34551871 | chr3:21490585-21490586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576047432 | chr3:21490596-21490597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10490884 | chr3:21490606-21490607 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs200277552 | chr3:21490613-21490614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539562780 | chr3:21490619-21490620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:21463000-21491400 | Weak transcription | Aorta | Aorta |
2 | chr3:21477000-21491200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr3:21477000-21507200 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr3:21483600-21491200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr3:21488400-21490200 | Enhancers | HSMM | muscle |
6 | chr3:21488400-21491200 | Weak transcription | Left Ventricle | heart |
7 | chr3:21489200-21491200 | Weak transcription | Ovary | ovary |
8 | chr3:21489200-21506600 | Weak transcription | Fetal Stomach | stomach |
9 | chr3:21489400-21490400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr3:21489400-21490400 | Enhancers | NHDF-Ad | bronchial |
11 | chr3:21489400-21490600 | Enhancers | Fetal Lung | lung |
12 | chr3:21489400-21491400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
13 | chr3:21490400-21491200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr3:21490600-21491000 | Weak transcription | Fetal Lung | lung |